June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry
Author Affiliations & Notes
  • Hao Wang
    ophthalmology, Shanghai tenth People’s Hospital, Shanghai, China
  • Le Feng
    ophthalmology, Shanghai tenth People’s Hospital, Shanghai, China
  • Fang Wang
    ophthalmology, Shanghai tenth People’s Hospital, Shanghai, China
  • Footnotes
    Commercial Relationships Hao Wang, None; Le Feng, None; Fang Wang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2703. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hao Wang, Le Feng, Fang Wang; Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2703.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

The aim of this study was to compare the protein profile of vitreous humour from diabetic patients with proliferative diabetic retinopathy with that from nondiabetic subjects with idiopathic epiretinal macular membranes.

 
Methods
 

Vitreous humour from type 2 diabetic patients with PDR (n=8) and from nondiabetic subjects with idiopathic epiretinal macular membranes (n=8) were studied. The comparative proteomic analysis was performed using reversed phase high-performance liquid chromatography coupled to electrospray Ionization tandem mass spectrometry.

 
Results
 

91 significant differentially expressed proteins (abundance ratio > 1.5, p < 0.05) were identified, including 37 and 54 proteins up- and downregulated in PDR vitreous compared with the control, respectively.

 
Conclusions
 

These data provide insight into the molecular events possibly involved in the pathogenesis of PDR and widen the scope of potential avenues for new therapies for PDR.

 
 
Process used to identify and quantify proteins by LC-ESI-MS/MS. The LC-MS data from the different groups was displayed as two-dimensional signal intensity maps with retention time and m/z on the two axes and a gray scale representing the intensity of a peak at a certain retention time and m/z. The chart represents m/z (vertical) versus retention time (horizontal).
 
Process used to identify and quantify proteins by LC-ESI-MS/MS. The LC-MS data from the different groups was displayed as two-dimensional signal intensity maps with retention time and m/z on the two axes and a gray scale representing the intensity of a peak at a certain retention time and m/z. The chart represents m/z (vertical) versus retention time (horizontal).
 
Keywords: 663 proteomics • 499 diabetic retinopathy • 763 vitreous  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×